Cancer
-
High consumption of vitamin E may lower liver cancer risk
iStock High consumption of vitamin E either from diet or vitamin supplements may lower the risk of liver cancer, according to a study published July 17 in the Journal of the National Cancer Institute. The study was conducted by investigators from the Shanghai Cancer Institute,… Read MoreJul 20, 2012
-
Childhood cancer investigator lands ‘Lemonade Stand’ grant
Chin Chiang, Ph.D., professor of Cell and Developmental Biology and member of the Vanderbilt-Ingram Cancer Center faculty, has been awarded a $200,000 grant to study an aggressive form of childhood cancer. Read MoreJul 12, 2012
-
Photo: Living well through cancer
Olympic gold medal skating champion and cancer survivor Scott Hamilton was the keynote speaker at Vanderbilt-Ingram Cancer Center’s annual cancer survivors day event held at the Vanderbilt Student Life Center. Nearly 600 people attended “Going for the Gold: Living Well through Cancer,” which featured activities for cancer… Read MoreJul 12, 2012
-
New cancer drug shows promise in early testing
An experimental drug that activates T-cells and promotes an immune response to fight tumors has shown promising early results in patients with kidney cancer, melanoma and non-small cell lung cancer. Leora Horn, M.D. Vanderbilt-Ingram Cancer Center investigators Leora Horn, M.D., Jeffrey Sosman, M.D., and researchers from several other cancer… Read MoreJul 12, 2012
-
It’s his metabolism: Research into cell processes could lead to breakthroughs for diabetes and cancer
Jamey Young, assistant professor of chemical and biomolecular engineering, likes to build bridges. But rather than physical structures, Young focuses on spanning the divide between biology and engineering, diabetes and cancer, and plants and animals. Read MoreJul 2, 2012
-
Kids’ cells okay after mom’s cancer radiation
Study finds no evidence of increased mitochondrial mutations in the children of women treated with radiation for cancer. Read MoreJun 22, 2012
-
Mixed results define 2012 Tennessee Men’s Health Report Card
Heart disease is still the leading cause of death for men in Tennessee and cancer deaths continue to move further away from the Centers for Disease Control and Prevention’s Healthy People 2020 goal, according to the 2012 Tennessee Men’s Health Report Card. Read MoreJun 12, 2012
-
Vanderbilt identifies genes linked to breast cancer chemo resistance
A study led by Vanderbilt-Ingram Cancer Center investigators has identified a gene expression pattern that may explain why chemotherapy prior to surgery isn’t effective against some tumors and suggests new therapy options for patients with specific subtypes of breast cancer. Read MoreJun 11, 2012
-
DNA: From modification to mutation
Understanding how an environmental hazard damages DNA may shed light on processes of tumor formation. Read MoreJun 8, 2012
-
Wilms’ tumors differ in developing nations
In addition to limited health care resources, biological factors may play a role in the poor survival of children with a common kidney cancer in developing nations. Read MoreApr 13, 2012
-
Factor sensitizes cancer to radiation
Measuring levels of an enzyme in head and neck tumors may indicate how the tumor will respond to radiation therapy. Read MoreApr 6, 2012
-
New York Times: Study says DNA’s power to predict illness is limited
Vanderbilt University is already doing genetic analyses of patients to help in developing a shortlist of effective drugs, says Dr. William Schaffner, chairman of the department of preventive medicine at its medical school. Read MoreApr 3, 2012
-
‘Detangler’ binds, bends and cuts DNA
New details on the DNA-cutting activity of topoisomerase II, a target of anti-cancer drugs, could lead to better chemotherapeutic agents. Read MoreMar 2, 2012
-
New melanoma drug nearly doubles survival in majority of patients
Investigators from Vanderbilt-Ingram Cancer Center and 12 other centers in the United States and Australia have found that a new drug for patients with metastatic melanoma nearly doubled median overall survival. Read MoreFeb 23, 2012
-
Prostate size may help in predicting cancer severity
Severity of cancer could be predicted by prostate size. Read MoreFeb 3, 2012
-
Dr. Michael Neuss: “How much progress has been made in the fight against cancer?”
Watch video of Dr. Michael Neuss speaking about the fight against cancer. Neuss spoke Feb. 1 as part of the Osher Lifelong Learning class, “Medical Advances.” The course is presented by faculty of the Vanderbilt University Medical Center and focuses on what the future of medicine holds. Physicians are now able… Read MoreFeb 2, 2012
-
Tracy Parsons, What’s Your Story?
Glen and Tracy Parsons (front) and their children (Daniel Dubois/Vanderbilt) At 10:30 p.m., the phone rang and woke Tracy Parsons from a sound sleep. She thought the call must be from her husband, Glen, a truck driver who was on the road that night. But caller ID read “Department… Read MoreFeb 1, 2012
-
Colorectal cancer risk related to gene’s expression
Individuals who are outside the normal range of expression for the adenomatous polyposis coli (APC) gene have an increased risk of colorectal cancer, according to a study published in the January issue of Gastroenterology. Read MoreJan 27, 2012
-
Investigators seek clues to resistance to melanoma drug
Investigators at Vanderbilt-Ingram Cancer Center and several other centers may be one step closer to finding out why some melanoma patients relapse after treatment with a promising new drug. Read MoreJan 26, 2012
-
Protein repairs esophageal DNA damage
A protein involved in repairing DNA damage associated with gastric reflux may play a tumor suppressor role in the esophagus and could represent a target for therapies to combat esophageal cancer. Read MoreJan 25, 2012